| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 318 | $53.61 | $17,047.98 | -0.1% | -23.9% | -74.5% | |
| Mar 30, 2022 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 17,704 | $45.12 | $798,808.99 | -2.0% | -47.8% | -49.5% | |
| Mar 28, 2022 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 686 | $39.63 | $27,185.43 | -0.5% | -1.3% | +34.5% | |
| Mar 28, 2022 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,605 | $39.63 | $103,233.28 | -4.1% | -1.3% | +34.5% | |
| Mar 28, 2022 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 1,382 | $39.63 | $54,767.14 | -50.3% | -1.3% | +34.5% | |
| Mar 28, 2022 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 134 | $39.63 | $5,310.27 | - | -1.3% | +34.5% | |
| Mar 28, 2022 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 915 | $39.63 | $36,260.44 | -1.1% | -1.3% | +34.5% | |
| Mar 25, 2022 | IMDX Insight Molecular Diagnostics Inc. | Ross Douglas T. | Chief Scientific Officer | Buy | 15,000 | $1.40 | $21,000.00 | +282.1% | -27.1% | -81.4% | |
| Mar 23, 2022 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 138 | $40.60 | $5,603.08 | - | -13.4% | +43.4% | |
| Mar 23, 2022 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 455 | $40.60 | $18,473.77 | -0.3% | -13.4% | +43.4% | |
| Mar 23, 2022 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 436 | $40.60 | $17,702.95 | -0.5% | -13.4% | +43.4% | |
| Mar 23, 2022 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 1,682 | $40.60 | $68,290.88 | -2.8% | -13.4% | +43.4% | |
| Mar 21, 2022 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 2,888 | $40.43 | $116,774.26 | -1.5% | -47.6% | -76.1% | |
| Mar 18, 2022 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 1,210 | $136.21 | $164,814.10 | -2.5% | -17.2% | -3.8% | |
| Mar 17, 2022 | XWEL Xwell, Inc. | Bernstein Bruce58 | Director | Buy | 5,000 | $1.23 | $6,150.00 | +0.7% | -51.2% | -73.8% | |
| Mar 17, 2022 | IMDX Insight Molecular Diagnostics Inc. | Paulsen Gisela | Chief Operating Officer | Buy | 16,500 | $1.20 | $19,767.00 | New | -23.9% | -80.1% | |
| Mar 16, 2022 | NTRA Natera, Inc. | Botha Roelof81 | Director | Buy | 153,000 | $32.72 | $5,005,411.13 | +4.3% | -7.3% | +66.4% | |
| Mar 16, 2022 | PMDI Psychemedics Corp | Kamin Peter | 10% Owner | Buy | 4,000 | $6.51 | $26,040.00 | +3.6% | - | - | |
| Mar 16, 2022 | IMDX Insight Molecular Diagnostics Inc. | Redmond Cavan M. | Director | Buy | 40,000 | $1.19 | $47,560.00 | +56.4% | -10.8% | -74.8% | |
| Mar 16, 2022 | IMDX Insight Molecular Diagnostics Inc. | Andrews Ronald Asbury | Chief Executive Officer | Buy | 50,000 | $1.28 | $64,150.00 | +20.6% | -10.8% | -74.8% | |
| Mar 15, 2022 | NOTV Inotiv, Inc. | Harkness James | Chief Operating Officer, Rms | Buy | 38,968 | $19.65 | $765,636.60 | +111.6% | -35.9% | -75.6% | |
| Mar 15, 2022 | IMDX Insight Molecular Diagnostics Inc. | Levine Mitchell S | Chief Financial Officer | Buy | 25,000 | $1.17 | $29,150.00 | +40.3% | -2.6% | -82.6% | |
| Mar 15, 2022 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 17,704 | $37.39 | $661,891.97 | -1.5% | -50.4% | -37.9% | |
| Mar 14, 2022 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 35,000 | $3.04 | $106,317.13 | - | -23.3% | -56.1% | |
| Mar 14, 2022 | RVTY Revvity, Inc. | Tereau Daniel R69 | Please See Remarks | Sell | 6,696 | $165.84 | $1,110,452.58 | -5.7% | -15.0% | -23.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.